Rational Design of Chlorinated Hydroxyxanthone as Anticancer Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET, One-Pot Synthesis, and In Vitro Evaluation
Cell Biochemistry and Biophysics · 2025
DOI: 10.1007/s12013-025-01796-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Yehezkiel Steven Kurniawan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia. Hauptthemen laut MEDLINE: Xanthones, Molecular Docking Simulation, Antineoplastic Agents, Molecular Dynamics Simulation. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Universitas Gadjah Mada.
Abstract (Originalsprache)
Nowadays, the discovery of active anticancer agents has become urgent research due to the high mortality of cancer patients. Herein, we designed some chlorinated hydroxyxanthones to examine the effect of the presence and position of the chloro group on the inhibitory activity of the PDGFR. The molecular docking reveals that 5-chloro-1-hydroxyxanthone (5Cl) exhibited the strongest binding energy (-7.95 kcal/mol) against PDGFR. The molecular dynamic simulation results demonstrated a high stability of the 5Cl-PDGFR complex as revealed by the average RMSD (0.37 ± 0.15 Å) and RMSF (0.83 ± 0.64 Å), and two maintained hydrogen bonds with Cys673 through hydroxyl and carbonyl groups with an average bond distance of 2.29 ± 0.54 and 2.49 ± 0.64 Å, respectively. Afterward, 5Cl and other chlorinated hydroxyxanthones were synthesized in a one-pot reaction with a 15.1-25.2% yield. From the in vitro experiment, 5Cl exhibited the lowest IC50 value of 3.065-3.785 µM against breast (MCF-7), cervical (HeLa), and colorectal (WiDr) cancer cells. Furthermore, 5Cl exhibited the highest selectivity index (8.737-10.79), showing that 5Cl is not toxic to the Vero normal cells, which agreed with the ADMET predictions. These findings highlight the potential application of 5Cl as a new anticancer agent that will be investigated further and developed in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia.
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia. jumina@ugm.ac.id.
- Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Förderung
- Universitas Gadjah Mada
Zitieren
APA
Kurniawan, Y. S., Harizal, Fatmasari, N., Yudha, E., Jumina, Pranowo, H. D., & Sholikhah, E. N. (2025). Rational Design of Chlorinated Hydroxyxanthone as Anticancer Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET, One-Pot Synthesis, and In Vitro Evaluation. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01796-1
Vancouver
Kurniawan YS, Harizal, Fatmasari N, Yudha E, Jumina, Pranowo HD, et al. Rational Design of Chlorinated Hydroxyxanthone as Anticancer Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET, One-Pot Synthesis, and In Vitro Evaluation. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-025-01796-1
BibTeX
@article{Kurniawan2025,
author = {Kurniawan, Yehezkiel Steven and Harizal and Fatmasari, Nela and Yudha, Ervan and Jumina and Pranowo, Harno Dwi and Sholikhah, Eti Nurwening},
title = {Rational Design of Chlorinated Hydroxyxanthone as Anticancer Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET, One-Pot Synthesis, and In Vitro Evaluation},
journal = {Cell Biochemistry and Biophysics},
year = {2025},
doi = {10.1007/s12013-025-01796-1}
}
EUVIMED